SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Mar 24, 2020
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: March 24, 2020 · CIK: 0001533998 · Accession: 0000000000-20-002571
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237275
Letter
March 24, 2020 Erez Raphael Chief Executive Officer DarioHealth Corp. 8 HaTokhen Street Caesarea Industrial Park 3088900, Israel Re:DarioHealth Corp. Registration Statement on Form S-3 Filed March 19, 2020 File No. 333-237275 Dear Mr. Raphael: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Oded Har-Even, Esq.
Show Raw Text
March 24, 2020
Erez Raphael
Chief Executive Officer
DarioHealth Corp.
8 HaTokhen Street
Caesarea Industrial Park
3088900, Israel
Re:DarioHealth Corp.
Registration Statement on Form S-3
Filed March 19, 2020
File No. 333-237275
Dear Mr. Raphael:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Oded Har-Even, Esq.